Balance Sheet
Accounts PayablesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Senti Biosciences (SNTI) Shares Outstanding (2021 - 2025)

Senti Biosciences has reported Shares Outstanding over the past 5 years, most recently at $30.9 million for Q4 2025.

  • Quarterly results put Shares Outstanding at $30.9 million for Q4 2025, up 539.45% from a year ago — trailing twelve months through Dec 2025 was $30.9 million (up 539.45% YoY), and the annual figure for FY2025 was $30.9 million, up 539.45%.
  • Shares Outstanding for Q4 2025 was $30.9 million at Senti Biosciences, up from $26.3 million in the prior quarter.
  • Over the last five years, Shares Outstanding for SNTI hit a ceiling of $43.6 million in Q3 2022 and a floor of $2.9 million in Q1 2021.
  • Median Shares Outstanding over the past 5 years was $4.6 million (2023), compared with a mean of $12.6 million.
  • Biggest five-year swings in Shares Outstanding: soared 1387.68% in 2022 and later plummeted 89.81% in 2023.
  • Senti Biosciences' Shares Outstanding stood at $3.0 million in 2021, then surged by 48.23% to $4.4 million in 2022, then grew by 3.72% to $4.6 million in 2023, then grew by 5.67% to $4.8 million in 2024, then skyrocketed by 539.45% to $30.9 million in 2025.
  • The last three reported values for Shares Outstanding were $30.9 million (Q4 2025), $26.3 million (Q3 2025), and $26.2 million (Q2 2025) per Business Quant data.